Clinical Trials

You are being asked to participate in this study because you have relapsed or refractory tumor without a proven treatment strategy for cure. The main goal is to test any good and bad effects of the...

You are being asked to participate in this study because you have a relapsed or refractory tumor without a proven treatment strategy for cure. The main goal of this study is to test any good and bad...

The main goal is to test any good and bad effects of the study drug selumetinib (AZD6244 hydrogen sulfate) on your tumor. A second goal of the study is to evaluate side effects that might be caused by...

This is a Phase 2 study of a drug called LY3023414. In a Phase 2 study, the goal is to find out what effects, good and/or bad, a drug has on your tumor or type of cancer.

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH or NAFL in clinical practice. TARGET-NASH will create a carefully maintained, actively monitored research...

Semaglutide is a medicine doctors can prescribe in some countries for the treatment of type 2 diabetes. A completed study showed that semaglutide reduced the risk of cardiovascular events (e.g. heart...

The size of the endotracheal tube (ETT) is based on a baby's weight, not on the size of the trachea. This practice increases the risk of selecting an ETT that is inappropriately small and leads to sub...

The purpose of the research repository is to collect information, which will be used for research studies to evaluate how clinical outcomes relate to Caris Molecular INtelligence Services.

The purpose of this research study is to see if regular exercise when combined with one of three commonly used high blood pressure medications can improve the physical abilities of older adults to...

To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:

BMI ≤35 kg/m2
65-90 years of age

Study Duration: Up to 120...

The overall goal of this study is to test any good and bad effects of the study drug LOXO-101 (larotrectinib) on your tumor.

Type 1 Diabetes (T1D) or Juvenile diabetes is an autoimmune disease projected to affect 5 million people, including 600,000 children in US alone, by the year 2050. There is currently no cure or...